Hodges; Alastair James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hodges; Alastair James.The latest application filed is for "novel compound useful for the treatement of degenerative and inflammatory diseases".

Company Profile

1.17.18

Hodges; Alastair James - Essex GB
Hodges; Alastair James - Saffron Walden GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds useful for the treatment of degenerative and inflammatory diseases Grant 10,206,907 - Menet , et al. Feb	2019-02-19
Compound useful for the treatement of degenerative and inflammatory diseases Grant 9,987,272 - Menet , et al. June 5, 2	2018-06-05
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use Grant 9,931,323 - Burch , et al. April 3, 2	2018-04-03
Novel Compound Useful For The Treatement Of Degenerative And Inflammatory Diseases App 20180078547 - MENET; Christel Jeanne Marie ; et al.	2018-03-22
Novel Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20170035738 - MENET; Christel Jeanne Marie ; et al.	2017-02-09
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use Grant 9,505,746 - Hodges , et al. November 29, 2	2016-11-29
Compounds useful for the treatment of degenerative and inflammatory diseases Grant 9,415,037 - Menet , et al. August 16, 2	2016-08-16
Cyclic Ether Pyrazol-4-YL-Heterocyclyl-Carboxamide Compounds And Methods Of Use App 20160213652 - Burch; Jason ; et al.	2016-07-28
Novel Compound Useful For The Treatement Of Degenerative And Inflammatory Diseases App 20160213666 - MENET; Christel Jeanne Marie ; et al.	2016-07-28
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use Grant 9,328,106 - Burch , et al. May 3, 2	2016-05-03
Compound useful for the treatment of degenerative and inflammatory diseases Grant 9,241,931 - Menet , et al. January 26, 2	2016-01-26
Novel Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20150150856 - MENET; Christel Jeanne Marie ; et al.	2015-06-04
Compound useful for the treatment of degenerative and inflammatory diseases Grant 8,975,406 - Menet , et al. March 10, 2	2015-03-10
Novel Compound Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20150031706 - MENET; Christel Jeanne Marie ; et al.	2015-01-29
Compounds useful for the treatment of degenerative and inflammatory diseases Grant 8,853,240 - Menet , et al. October 7, 2	2014-10-07
Compound useful for the treatment of degenerative and inflammatory diseases Grant 8,802,682 - Menet , et al. August 12, 2	2014-08-12
Cyclic Ether Pyrazol-4-yl-heterocyclyl-carboxamide Compounds And Methods Of Use App 20140088117 - Burch; Jason ; et al.	2014-03-27
Pyrazol-4-yl-heterocyclyl-carboxamide Compounds And Methods Of Use App 20140080801 - Hodges; Alastair James ; et al.	2014-03-20
Novel Compound Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20140051677 - Menet; Christel Jeanne Marie ; et al.	2014-02-20
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use Grant 8,614,206 - Hodges , et al. December 24, 2	2013-12-24
Pyrazol-4-yl-heterocyclyl-carboxamide Compounds And Methods Of Use App 20130079321 - Hodges; Alastair James ; et al.	2013-03-28
Novel Compound Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20120277247 - Menet; Christel Jeanne Marie ; et al.	2012-11-01
Novel Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases App 20110190260 - Menet; Christel Jeanne Marie ; et al.	2011-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.